ClinicalTrials.gov record
A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)
ClinicalTrials.gov ID: NCT02145468
Public ClinicalTrials.gov record NCT02145468. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (PM1116197) LosmApimod To Inhibit p38 MAP Kinase as a TherapeUtic Target and moDify Outcomes After an Acute Coronary syndromE (LATITUDE)-TIMI 60.
Study identification
- NCT ID
- NCT02145468
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 3,503 participants
Conditions and interventions
Conditions
Interventions
- Losmapimod 7.5 mg twice daily Drug
- Placebo twice daily Drug
- Standard therapy Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2, 2014
- Primary completion
- Dec 13, 2015
- Completion
- Dec 13, 2015
- Last update posted
- Jun 1, 2017
2014 – 2015
United States locations
- U.S. sites
- 91
- U.S. states
- 32
- U.S. cities
- 86
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Huntsville | Alabama | 35801 | — |
| GSK Investigational Site | Cottonwood | Arizona | 86326 | — |
| GSK Investigational Site | Tucson | Arizona | 85713 | — |
| GSK Investigational Site | Tucson | Arizona | 85724 | — |
| GSK Investigational Site | Jonesboro | Arkansas | 72401 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72205 | — |
| GSK Investigational Site | Bakersfield | California | 93308 | — |
| GSK Investigational Site | Huntington Beach | California | 92648 | — |
| GSK Investigational Site | Long Beach | California | 90806 | — |
| GSK Investigational Site | Mission Viejo | California | 92691 | — |
| GSK Investigational Site | Monterey | California | 93940 | — |
| GSK Investigational Site | Orange | California | 92868 | — |
| GSK Investigational Site | San Diego | California | 92161 | — |
| GSK Investigational Site | Torrance | California | 90509 | — |
| GSK Investigational Site | Denver | Colorado | 80204 | — |
| GSK Investigational Site | Littleton | Colorado | 80120 | — |
| GSK Investigational Site | Daytona Beach | Florida | 32117 | — |
| GSK Investigational Site | Jacksonville | Florida | 32207 | — |
| GSK Investigational Site | Jacksonville | Florida | 32209 | — |
| GSK Investigational Site | Jacksonville Beach | Florida | 32250 | — |
| GSK Investigational Site | Ocala | Florida | 34471 | — |
| GSK Investigational Site | Pensacola | Florida | 32501 | — |
| GSK Investigational Site | Tallahassee | Florida | 32308 | — |
| GSK Investigational Site | Tampa | Florida | 33613 | — |
| GSK Investigational Site | Vero Beach | Florida | 32960 | — |
| GSK Investigational Site | Augusta | Georgia | 30901 | — |
| GSK Investigational Site | Rome | Georgia | 30165 | — |
| GSK Investigational Site | Coeur d'Alene | Idaho | 83814 | — |
| GSK Investigational Site | Aurora | Illinois | 60504 | — |
| GSK Investigational Site | Elmhurst | Illinois | 60126 | — |
| GSK Investigational Site | Indianapolis | Indiana | 46237 | — |
| GSK Investigational Site | Muncie | Indiana | 47303 | — |
| GSK Investigational Site | Iowa City | Iowa | 52240 | — |
| GSK Investigational Site | West Des Moines | Iowa | 50266 | — |
| GSK Investigational Site | Alexandria | Louisiana | 71301 | — |
| GSK Investigational Site | Baton Rouge | Louisiana | 70809 | — |
| GSK Investigational Site | Slidell | Louisiana | 70458 | — |
| GSK Investigational Site | Zachary | Louisiana | 70791 | — |
| GSK Investigational Site | Auburn | Maine | 04210 | — |
| GSK Investigational Site | Boston | Massachusetts | 02115 | — |
| GSK Investigational Site | Dearborn | Michigan | 48124 | — |
| GSK Investigational Site | Grand Blanc | Michigan | 48439 | — |
| GSK Investigational Site | Marquette | Michigan | 49855 | — |
| GSK Investigational Site | Rochester | Michigan | 48307 | — |
| GSK Investigational Site | Troy | Michigan | 48085 | — |
| GSK Investigational Site | Ypsilanti | Michigan | 48197 | — |
| GSK Investigational Site | Duluth | Minnesota | 55805 | — |
| GSK Investigational Site | Minneapolis | Minnesota | 55407 | — |
| GSK Investigational Site | Saint Paul | Minnesota | 55101 | — |
| GSK Investigational Site | Kansas City | Missouri | 64114 | — |
| GSK Investigational Site | Springfield | Missouri | 65804 | — |
| GSK Investigational Site | St Louis | Missouri | 63110 | — |
| GSK Investigational Site | Omaha | Nebraska | 68124 | — |
| GSK Investigational Site | Omaha | Nebraska | 68131 | — |
| GSK Investigational Site | Flemington | New Jersey | 08822 | — |
| GSK Investigational Site | Ridgewood | New Jersey | 07450 | — |
| GSK Investigational Site | Teaneck | New Jersey | 07666 | — |
| GSK Investigational Site | Voorhees Township | New Jersey | 08043 | — |
| GSK Investigational Site | Albany | New York | 12208 | — |
| GSK Investigational Site | Poughkeepsie | New York | 12601 | — |
| GSK Investigational Site | Stony Brook | New York | 11794 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28204 | — |
| GSK Investigational Site | Greensboro | North Carolina | 27401 | — |
| GSK Investigational Site | Raleigh | North Carolina | 27607 | — |
| GSK Investigational Site | Raleigh | North Carolina | 27610 | — |
| GSK Investigational Site | Canton | Ohio | 44710 | — |
| GSK Investigational Site | Cleveland | Ohio | 44106 | — |
| GSK Investigational Site | Columbus | Ohio | 45215 | — |
| GSK Investigational Site | Mansfield | Ohio | 44906 | — |
| GSK Investigational Site | Zanesville | Ohio | 43701 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73135 | — |
| GSK Investigational Site | Abington | Pennsylvania | 19001 | — |
| GSK Investigational Site | Chambersburg | Pennsylvania | 17201 | — |
| GSK Investigational Site | Danville | Pennsylvania | 17822-2160 | — |
| GSK Investigational Site | Doylestown | Pennsylvania | 18901 | — |
| GSK Investigational Site | Wilkes-Barre | Pennsylvania | 18702 | — |
| GSK Investigational Site | York | Pennsylvania | 17403 | — |
| GSK Investigational Site | Anderson | South Carolina | 29621 | — |
| GSK Investigational Site | Rapid City | South Dakota | 57701 | — |
| GSK Investigational Site | Chattanooga | Tennessee | 37404-1173 | — |
| GSK Investigational Site | Nashville | Tennessee | 37203 | — |
| GSK Investigational Site | Nashville | Tennessee | 37205 | — |
| GSK Investigational Site | Austin | Texas | 78756 | — |
| GSK Investigational Site | Dallas | Texas | 75216 | — |
| GSK Investigational Site | Round Rock | Texas | 78681 | — |
| GSK Investigational Site | Victoria | Texas | 77901 | — |
| GSK Investigational Site | Roanoke | Virginia | 24014 | — |
| GSK Investigational Site | Tacoma | Washington | 98405 | — |
| GSK Investigational Site | Morgantown | West Virginia | 26506 | — |
| GSK Investigational Site | Manitowoc | Wisconsin | 54220 | — |
| GSK Investigational Site | Wausau | Wisconsin | 54401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 250 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02145468, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02145468 live on ClinicalTrials.gov.